Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu, Chengfei Zhao, Chen WenBiao, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 27, pp. 4298-4321
Open Access | Times Cited: 378

Showing 1-25 of 378 citing articles:

Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silvius Stanciu, Florentina Ioniţă‐Radu, Constantin Ștefani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10132-10132
Open Access | Times Cited: 76
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk
Robert Wilson, Dhruvi Lathigara, Devesh Kaushal
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6192-6192
Open Access | Times Cited: 65
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
Tianxing Zhou, Yongjie Xie, Xupeng Hou, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 50
Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
Dimitrios Stefanoudakis, Maximos Frountzas, Dimitriοs Schizas, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2827-2844
Open Access | Times Cited: 20
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 16
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Di Jin, Najeeb Ullah Khan, Wei Gu, et al.
Neoplasia (2025) Vol. 60, pp. 101129-101129
Closed Access | Times Cited: 2
Liposome-based diagnostic and therapeutic applications for pancreatic cancer
Faisal Raza, Lauren Evans, Mahzad Motallebi, et al.
Acta Biomaterialia (2022) Vol. 157, pp. 1-23
Open Access | Times Cited: 51
Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
Jay Z. Natu, Ganji Purnachandra Nagaraju
Cancer Letters (2023) Vol. 573, pp. 216382-216382
Open Access | Times Cited: 33
Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis—A Narrative Review
Dhruvi Lathigara, Devesh Kaushal, Robert Wilson
Metabolites (2023) Vol. 13, Iss. 5, pp. 675-675
Open Access | Times Cited: 32
Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029
Youli Chen, Tianhui Chen, Jing‐Yuan Fang
Cancer Letters (2023) Vol. 560, pp. 216127-216127
Closed Access | Times Cited: 26
Genetic and non-genetic risk factors for early-onset pancreatic cancer
Ylenia Nodari, Manuel Gentiluomo, Beatrice Mohelníková-Duchoňová, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 10, pp. 1417-1425
Open Access | Times Cited: 24
Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
Bethsebie Lalduhsaki Sailo, Le Liu, Suravi Chauhan, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access | Times Cited: 13
Fabrication of magnetic niosomal platform for delivery of resveratrol: potential anticancer activity against human pancreatic cancer Capan-1 cell
Akram Firouzi Amandi, Zahra Bahmanyar, Mehdi Dadashpour, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Potential utilization of ferulic acid and its derivatives in the management of metabolic diseases and disorders: An insight into mechanisms
Mst Muslima Khatun, Md. Shimul Bhuia, Raihan Chowdhury, et al.
Cellular Signalling (2024) Vol. 121, pp. 111291-111291
Closed Access | Times Cited: 8
Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity
Heba T. Abdel‐Mohsen, Yasmin M. Syam, Mahmoud S. Abd El‐Ghany, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 8
Novel Drug Delivery Particles Can Provide Dual Effects on Cancer “Theranostics” in Boron Neutron Capture Therapy
Abdul Basith Fithroni, Haruki Inoue, Shengli Zhou, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 60-60
Open Access | Times Cited: 1
Ethnic/Racial Disparities in Pancreatic Cancer Mortality Across the United States: A National Inpatient Sample Database Analysis
Catherine D Fuko, Hezborn M Magacha, Gideon U Noah, et al.
Cureus (2025)
Open Access | Times Cited: 1
TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005491-e005491
Open Access | Times Cited: 28
PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2923-2923
Open Access | Times Cited: 21
A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions
Fred G. Karaisz, Osama O. Elkelany, Ben Davies, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 536-536
Open Access | Times Cited: 20
LMNS-Net: Lightweight Multiscale Novel Semantic-Net deep learning approach used for automatic pancreas image segmentation in CT scan images
Pradip Paithane, Sangeeta Kakarwal
Expert Systems with Applications (2023) Vol. 234, pp. 121064-121064
Closed Access | Times Cited: 17
In situ self-assembled nanomedicines for cancer treatment
Xinxin Sun, Xiaohong Yang, Yao Chen, et al.
Chemical Engineering Journal (2023) Vol. 466, pp. 143365-143365
Closed Access | Times Cited: 16
Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis
Zemin Zhu, Bo Yi, Z Tang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases
Shmuel Silnitsky, Samuel J. S. Rubin, Mulate Zerihun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17600-17600
Open Access | Times Cited: 16
Epidemiology of pancreatic cancer
Belma Muratović, Aleksandra Nikolić
Zdravstvena zastita (2023) Vol. 52, Iss. 4, pp. 36-49
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top